FDA’s 5-Year Plan For User Fees Puts Post- And Pre-Market On Equal Footing
Executive Summary
Over the next five years, FDA will shift its regulatory focus to ensure that the safe and effective use of drugs is of equal importance as ushering safe and effective medicines to market